We are live on !
Find out more
Brian C. Broderick Portfolio holdings
AUM
$646M
Turnover
6.12%
1-Year Est. Return
43.3%
This Fund
S&P 500
This Quarter Est. Return
+1.27%
1 Year Est. Return
+43.3%
3 Year Est. Return
+98.62%
5 Year Est. Return
+125.42%
10 Year Est. Return
+408.39%
AUM
$231M
AUM Growth
-$3.86M
(-1.6%)
Cap. Flow
-$2.84M
Cap. Flow % of AUM
Cap. Flow %
-1.23%
Top 10 Holdings %
Top 10 Hldgs %
35.2%
Holding
100
New
1
Increased
14
Reduced
55
Closed
7
Avg Time Held
2.7
years
Top 10 Avg Time Held
2.5
years
Top 20 Avg Time Held
2.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Analog Devices
ADI
|
+$1.13M |
| 2 |
Danaher
DHR
|
+$858K |
| 3 |
Chubb
CB
|
+$540K |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$443K |
| 5 |
J.M. Smucker
SJM
|
+$441K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$1.66M |
| 2 |
Unilever
UL
|
+$669K |
| 3 |
Johnson Controls International
JCI
|
+$465K |
| 4 |
Kroger
KR
|
+$380K |
| 5 |
Cisco
CSCO
|
+$328K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.25% |
| 2 | Technology | 22.44% |
| 3 | Industrials | 17.34% |
| 4 | Consumer Staples | 9.36% |
| 5 | Energy | 7.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Johnson & Johnson
JNJ
$670B
| $9.9M | 4.29% |
85,991
-935
| -1% | -$108K |
2013 Q2
14 quarters
|
|
2
Procter & Gamble
PG
$387B
| $9.8M | 4.23% |
116,104
-1,132
| -1% | -$96.5K |
2013 Q2
14 quarters
|
|
3
3M
MMM
$98.1B
| $9.44M | 4.09% |
63,260
-324
| -0.5% | -$46.8K |
2013 Q2
14 quarters
|
|
4
Automatic Data Processing
ADP
$120B
| $8.7M | 3.77% |
84,660
-1,023
| -1% | -$95.4K |
2013 Q2
14 quarters
|
|
5
ExxonMobil
XOM
$677B
| $8.26M | 3.58% |
91,519
+373
| +0.4% | +$32.6K |
2013 Q2
14 quarters
|
|
6
Canadian National Railway
CNI
$76.3B
| $7.44M | 3.23% |
110,450
-434
| -0.4% | -$28.6K |
2013 Q2
14 quarters
|
|
7
AptarGroup
ATR
$9.07B
| $7.12M | 3.08% |
96,920
+1,765
| +2% | +$131K |
2013 Q2
14 quarters
|
|
8
CVS Health
CVS
$113B
| $7.01M | 3.04% |
88,816
-1,840
| -2% | -$149K |
2013 Q2
14 quarters
|
|
9
Apple
AAPL
$5.16T
| $6.64M | 2.88% |
229,384
-2,356
| -1% | -$66.8K |
2013 Q2
14 quarters
|
|
10
Novartis
NVS
$302B
| $6.46M | 2.8% |
98,940
-536
| -0.5% | -$34.8K |
2013 Q2
14 quarters
|
|
11
Home Depot
HD
$349B
| $6.29M | 2.73% |
46,913
-595
| -1% | -$76.7K |
2013 Q2
14 quarters
|
|
12
Mastercard
MA
$572B
| $6.25M | 2.71% |
60,530
+2,270
| +4% | +$235K |
2013 Q2
14 quarters
|
|
13
Fiserv Inc
FISV
$33.8B
| $6.2M | 2.69% |
116,640
-1,300
| -1% | -$66.8K |
2013 Q2
14 quarters
|
|
|
14
Alphabet (Google) Class A
GOOGL
$3.63T
| $5.93M | 2.57% |
149,560
+11,080
| +8% | +$443K |
2015 Q3
5 quarters
|
|
15
Intel
INTC
$336B
| $5.79M | 2.51% |
159,632
-800
| -0.5% | -$28.6K |
2013 Q2
14 quarters
|
|
16
Rockwell Automation
ROK
$45.9B
| $5.06M | 2.19% |
37,634
-100
| -0.3% | -$12.8K |
2013 Q2
14 quarters
|
|
|
17
Chubb
CB
$140B
| $4.88M | 2.12% |
36,975
+4,235
| +13% | +$540K |
2015 Q3
5 quarters
|
|
18
Abbott
ABT
$190B
| $4.23M | 1.83% |
110,015
+1,015
| +0.9% | +$40.2K |
2013 Q2
14 quarters
|
|
|
XLNX
19
DELISTED
Xilinx Inc
XLNX
| $4.14M | 1.79% |
68,645
-315
| -0.5% | -$16.9K |
2013 Q2
14 quarters
|
|
20
RTX Corp
RTX
$270B
| $4.06M | 1.76% |
58,879
+3,711
| +7% | +$246K |
2013 Q2
14 quarters
|
|
21
PepsiCo
PEP
$194B
| $3.86M | 1.67% |
36,878
-675
| -2% | -$70.7K |
2013 Q2
14 quarters
|
|
22
Oracle
ORCL
$405B
| $3.8M | 1.65% |
98,867
-650
| -0.7% | -$25.4K |
2013 Q2
14 quarters
|
|
23
NXP Semiconductors
NXPI
$68.9B
| $3.44M | 1.49% |
35,040
| – | – |
2013 Q2
14 quarters
|
|
|
24
Danaher
DHR
$165B
| $3.24M | 1.4% |
46,909
+12,363
| +36% | +$858K |
2016 Q1
3 quarters
|
|
25
GE Aerospace
GE
$354B
| $3.17M | 1.37% |
20,932
-148
| -0.7% | -$21.5K |
2013 Q2
14 quarters
|
|
Similar funds
JCP
Brian C. Broderick's Q4 2016 Portfolio in Review
As of Q4 2016, Brian C. Broderick held 100 positions worth $231M, down 1.6% from $235M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Brian C. Broderick's Q4 2016 filing shows 1 new, 14 increased, 55 reduced and 7 closed positions. Its largest new stake was Royal Bank of Canada: 3,000 shares worth $203K. The largest sale was Target, an estimated $1.66M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.
- Brian C. Broderick's largest Q4 2016 buy was Royal Bank of Canada: 3,000 shares worth $203K.
- Brian C. Broderick added most to Analog Devices in Q4 2016, an estimated $1.13M increase.
- Brian C. Broderick's biggest Q4 2016 reduction was Target, cutting an estimated $1.66M.
- Brian C. Broderick fully exited Johnson Controls International in Q4 2016, selling an estimated $465K.
- Brian C. Broderick's ten largest holdings make up 35% of its $231M portfolio in Q4 2016.
- Brian C. Broderick opened 1 new position and closed 7 in Q4 2016.
- Brian C. Broderick's portfolio value fell 1.6% quarter-over-quarter to $231M.
Based on Brian C. Broderick's 13F filing for Q4 2016, filed 14 Feb 2017.